相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study
Dirk Jan A. R. Moes et al.
CLINICAL PHARMACOKINETICS (2022)
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia
Garth W. Strohbehn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Rogan A. Grant et al.
NATURE (2021)
Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
Yojana Gokhale et al.
BMC INFECTIOUS DISEASES (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
IL-6 blockade for COVID-19: a global scientific call to arms
Srinivas Murthy et al.
LANCET RESPIRATORY MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Tocilizumab in Treatment for Patients With COVID-19
Chengliang Yang et al.
JAMA INTERNAL MEDICINE (2021)
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
Oliver J. McElvaney et al.
LANCET RESPIRATORY MEDICINE (2021)
Socially optimal pandemic drug dosing
Garth W. Strohbehn et al.
LANCET GLOBAL HEALTH (2021)
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
Marios Koutsakos et al.
CELL REPORTS MEDICINE (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: Clean up on IL-6
Tanner L. Hedrick et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping et al.
CELL (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Interleukin-6 in Covid-19: A systematic review andmeta-analysis
Eric A. Coomes et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
Daniel E. Leisman et al.
LANCET RESPIRATORY MEDICINE (2020)
Effects of Tocilizumab in COVID-19 patients: a cohort study
Christine A. Vu et al.
BMC INFECTIOUS DISEASES (2020)
Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study
Tariq Kewan et al.
ECLINICALMEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Noa Biran et al.
LANCET RHEUMATOLOGY (2020)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy
Fang Chen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation
Sardar Sindhu et al.
PLOS ONE (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
A Guide to Rational Dosing of Monoclonal Antibodies
Shuang Bai et al.
CLINICAL PHARMACOKINETICS (2012)
Drug Dosing Based on Weight and Body Surface Area: Mathematical Assumptions and Limitations in Obese Adults
Manjunath P. Pai
PHARMACOTHERAPY (2012)
Evaluation of TNF-a and IL-6 levels in obese and non-obese diabetics: Pre- and postinsulin effects
Rajeev Goyal et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
Laura Campbell et al.
RHEUMATOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Concepts and Lessons for Drug Development
Diane R. Mould et al.
BIODRUGS (2010)
Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
Nicolas Frey et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Estimated Lean Body Mass Is More Appropriate than Body Surface Area for Scaling Glomerular Filtration Rate and Extracellular Fluid Volume
A. Michael Peters et al.
NEPHRON CLINICAL PRACTICE (2010)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
Norihiro Nishimoto et al.
BLOOD (2008)
High-dose glucocorticoids increase serum levels of soluble IL-6 receptor α and its ratio to soluble gp130:: an additional mechanism for early increased bone resorption
Andrea Dovio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Estimating blood volume in obese and morbidly obese patients
HJM Lemmens et al.
OBESITY SURGERY (2006)
分享论文
